Ainos, Inc.
AIMDTechnologyNASDAQScientific & Technical Instruments · Last scanned Oct 26, 2026
Scan Results
Daily timeframeAinos, Inc., a dual-platform company, focusing artificial intelligencebased smelltech technologies and immune therapeutics. With a market capitalization of $6.2M, it sits in micro-cap territory. It offers AI Nose, an AI-based electronic olfaction system, which uses a smell language model to digitize scent into Smell IDs and turning into machine-readable data.
Market Cap
$6.2M
Beta
2.48
P/E (TTM)
—
P/E (Fwd)
—
EPS (TTM)
$-2.54
EPS (Fwd)
—
ROE
-196.3%
ROA
-39.6%
Cash
$1.4M
Total Debt
$13.8M
Free CF
$1.8M
52W Change
-76.8%
Annual Financials
Cash vs Debt
Where AIMD stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, AIMD finished 42.24% below its 150-day moving average ($1.61) and 43.29% below its 200-day moving average ($1.64). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is AIMD overbought or oversold?
At the October 20, 2026 close, AIMD's RSI(14) was 22.0, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Ainos, Inc. carries $13.8M in total debt against $1.4M in cash reserves — debt is roughly 9.7x the cash position. Managing this leverage effectively will be important for long-term financial stability. The company generates $1.8M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at -196.3%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has been uneven over recent years, ranging from $595K to $124K.
With a beta above 1.5, AIMD tends to amplify broader market moves — both up and down. This higher volatility means larger price swings are common. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. No single metric tells the full story. Reviewing AIMD's risk profile alongside its fundamentals and technical indicators provides a more complete picture.